Ensign Peak Advisors, Inc
- SEC CIK
- 0001454984
- Latest filing
- Aug 14, 2026
RLAY holding history
Relay Therapeutics, Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLAY overviewAll 13F holders of RLAYFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −64,900−100.0% | Sold out | Holders |
| Q1 2025 | 64,900 | $170.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 64,900 | $267.4K | <0.1% | +9,450+17.0% | Added | Holders |
| Q3 2024 | 55,450 | $392.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 55,450 | $361.5K | <0.1% | +10,850+24.3% | Added | Holders |
| Q1 2024 | 44,600 | $370.2K | <0.1% | −2,250−4.8% | Reduced | Holders |
| Q4 2023 | 46,850 | $515.8K | <0.1% | +7,950+20.4% | Added | Holders |
| Q3 2023 | 38,900 | $327.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 38,900 | $488.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 38,900 | $640.7K | <0.1% | +38,900 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −16,870−100.0% | Sold out | Holders |
| Q3 2022 | 16,870 | $377.0K | <0.1% | +12,210+262.0% | Added | Holders |
| Q2 2022 | 4,660 | $78.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 4,660 | $139.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 4,660 | $143.0K | <0.1% | +4,660 | New | Holders |